LENAERTS VINCENT has a total of 20 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, EPO (European Patent Office) and Poland. Its main competitors in its focus markets pharmaceuticals and macromolecular chemistry and polymers are ULTRACEUTICALS R & D PTY LTD, ZOPPETTI GIORGIO and ATEN PORUS LIFESCIENCES.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Poland | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Argentina | 1 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | Czechia | 1 | |
#10 | Hong Kong | 1 | |
#11 | Hungary | 1 | |
#12 | Mexico | 1 | |
#13 | Malaysia | 1 | |
#14 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Polysaccharides |
# | Name | Total Patents |
---|---|---|
#1 | Lenaerts Vincent | 18 |
#2 | Chouinard Francois | 15 |
#3 | Beck Roland Herwig Friedrich | 9 |
#4 | Hopcke Reiner | 8 |
#5 | Desevaux Cyril | 8 |
#6 | Bogaert Elsie Van | 7 |
#7 | Ispas-Szabo Pompilia | 7 |
#8 | Mateescu Mircea A | 6 |
#9 | Gervais Sonia | 2 |
#10 | Smith Damon | 2 |
Publication | Filing date | Title |
---|---|---|
US2006240107A1 | Controlled-release compositions | |
US2006172006A1 | Sustained-release tramadol formulations with 24-hour clinical efficacy | |
AU2001271481B2 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture | |
EP1059915A1 | Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents |